318 related articles for article (PubMed ID: 16686)
21. Persistence of beta-adrenergic receptors in rat striatum following kainic acid administration.
Zahniser NR; Minneman KP; Molinoff PB
Brain Res; 1979 Dec; 178(2-3):589-95. PubMed ID: 228797
[No Abstract] [Full Text] [Related]
22. Muscarinic and dopaminergic receptor subtypes on striatal cholinergic interneurons.
Dawson VL; Dawson TM; Wamsley JK
Brain Res Bull; 1990 Dec; 25(6):903-12. PubMed ID: 2149667
[TBL] [Abstract][Full Text] [Related]
23. Cortical neurochemical changes after intrastriatal injection of kainic acid.
Hruska RE; Silbergeld EK
Brain Res; 1980 Jun; 191(2):572-6. PubMed ID: 6103736
[No Abstract] [Full Text] [Related]
24. Chronic taurine effects on various neurochemical indices in control and kainic acid-lesioned neostriatum.
Sanberg PR; Staines W; McGeer EG
Brain Res; 1979 Feb; 161(2):367-70. PubMed ID: 31967
[No Abstract] [Full Text] [Related]
25. Some factors influencing the neurotoxicity of intrastriatal injections of kainic acid.
McGeer EG; McGeer PL
Neurochem Res; 1978 Aug; 3(4):501-17. PubMed ID: 34114
[TBL] [Abstract][Full Text] [Related]
26. Organotypic slice cultures of the rat striatum--I. A histochemical and immunocytochemical study of acetylcholinesterase, choline acetyltransferase, glutamate decarboxylase and GABA.
Ostergaard K
Neuroscience; 1993 Apr; 53(3):679-93. PubMed ID: 8487950
[TBL] [Abstract][Full Text] [Related]
27. Changes in striatal cholinergic, gabaergic, dopaminergic and serotoninergic biochemical markers after kainic acid-induced thalamic lesions in the rat.
Samuel D; Kerkerian-Le Goff L; Kumar U; Errami M; Scarfone E; Nieoullon A
J Neural Transm Park Dis Dement Sect; 1990; 2(3):193-203. PubMed ID: 1979492
[TBL] [Abstract][Full Text] [Related]
28. Kainic acid-induced changes of serotonin and dopamine metabolism in the striatum and substantia nigra of the rat.
Sperk G; Berger M; Hörtnagl H; Hornykiewicz O
Eur J Pharmacol; 1981 Sep; 74(4):279-86. PubMed ID: 6170518
[TBL] [Abstract][Full Text] [Related]
29. Changes in choline acetyltransferase, glutamic acid decarboxylase, high-affinity glutamate uptake and dopaminergic activity induced by kainic acid lesion of the thalamostriatal neurons.
Nieoullon A; Scarfone E; Kerkerian L; Errami M; Dusticier N
Neurosci Lett; 1985 Aug; 58(3):299-304. PubMed ID: 2864669
[TBL] [Abstract][Full Text] [Related]
30. [Effect of intracaudate administration of kainic acid on the activity of the dopaminergic system].
Zharkovskiĭ AM; Nurk AM
Fiziol Zh SSSR Im I M Sechenova; 1981 Nov; 67(11):1606-10. PubMed ID: 6799331
[TBL] [Abstract][Full Text] [Related]
31. Neural grafting in a rat model of Huntington's disease: progressive neurochemical changes after neostriatal ibotenate lesions and striatal tissue grafting.
Isacson O; Brundin P; Gage FH; Björklund A
Neuroscience; 1985 Dec; 16(4):799-817. PubMed ID: 2936982
[TBL] [Abstract][Full Text] [Related]
32. Regional brain atrophy and reductions in glutamate release and uptake after intrastriatal kainic acid.
Friedle NM; Kelly PH; Moore KE
Br J Pharmacol; 1978 May; 63(1):151-8. PubMed ID: 148306
[TBL] [Abstract][Full Text] [Related]
33. In situ injection of kainic acid: a new method for selectively lesioning neural cell bodies while sparing axons of passage.
Coyle JT; Molliver ME; Kuhar MJ
J Comp Neurol; 1978 Jul; 180(2):301-23. PubMed ID: 659663
[TBL] [Abstract][Full Text] [Related]
34. Gamma-aminobutyric acid turnover in rat striatum: effects of glutamate and kainic acid.
Giorgi O; Meek JL
J Neurochem; 1984 Jan; 42(1):215-20. PubMed ID: 6139420
[TBL] [Abstract][Full Text] [Related]
35. Amphetamine-induced locomotor activity and stereotypy after kainic acid lesions of the striatum.
Mason ST; Sanberg PR; Fibiger HC
Life Sci; 1978 Feb; 22(6):451-9. PubMed ID: 24160
[No Abstract] [Full Text] [Related]
36. MIF-I and postsynaptic receptor sites for dopamine.
Kostrzewa RM; Hardin JC; Snell RL; Kastin AJ; Coy DH; Bymaster F
Brain Res Bull; 1979; 4(5):657-62. PubMed ID: 39665
[TBL] [Abstract][Full Text] [Related]
37. Kainic acid lesion of mouse striatum: effects on energy metabolites.
Retz KC; Coyle JT
Life Sci; 1980 Dec 22-29; 27(25-26):2495-500. PubMed ID: 6111722
[No Abstract] [Full Text] [Related]
38. Cortical modulation of striatal function.
Scatton B; Worms P; Lloyd KG; Bartholini G
Brain Res; 1982 Jan; 232(2):331-43. PubMed ID: 6200179
[TBL] [Abstract][Full Text] [Related]
39. Impaired learning and memory after kainic acid lesions of the striatum: a behavioral model of Huntington's disease.
Sanberg PR; Lehmann J; Fibiger HC
Brain Res; 1978 Jun; 149(2):546-51. PubMed ID: 27285
[No Abstract] [Full Text] [Related]
40. Kainic acid lesions of the striatum in rats mimic the spontaneous motor abnormalities of Huntington's Disease.
Mason ST; Fibiger HC
Neuropharmacology; 1979 Apr; 18(4):403-7. PubMed ID: 36573
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
